Combined gastrin releasing peptide-29 and glucagon like peptide-1 reduce body weight more than each individual peptide in diet-induced obese male rats

被引:6
作者
Mhalhal, Thaer R. [1 ,2 ]
Washington, Martha C. [1 ]
Newman, Kayla D. [1 ]
Heath, John C. [1 ]
Sayegh, Ayman I. [1 ]
机构
[1] Tuskegee Univ, Coll Vet Med, Dept Biomed Sci, Gastroenterol Lab, Tuskegee, AL 36088 USA
[2] Univ Basrah, Coll Vet Med, Dept Anat & Histol, Basrah, Iraq
关键词
Glucagon-like peptide-1; Gastrin releasing peptide-29; Body weight; Aorta; Glucose; Diet-induced obese rats; DEPENDENT INSULINOTROPIC POLYPEPTIDE; INTERMEAL INTERVAL LENGTH; BOMBESIN-RELATED PEPTIDES; SPONTANEOUS MEAL SIZE; SHORT-TERM CONTROL; FOOD-INTAKE; GASTROINTESTINAL SITES; GLP-1; RECEPTORS; CHOLECYSTOKININ; SECRETION;
D O I
10.1016/j.npep.2017.11.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To test the hypothesis that gastrin releasing peptide-29 (GRP-29) combined with glucagon like peptide-1 (7-36) (GLP-1 (7-36)) reduce body weight (BW) more than each of the peptides given individually, we infused the two peptides (0.5 nmol/kg each) in the aorta of free feeding, diet-induced obese (DIO) male Sprague Dawley rats once daily for 25 days and measured BW. We found that GRP-29 and GLP-1 reduce BW, GRP-29 reduced it more than GLP-1 and GRP-29 + GLP-1 reduce BW more than each peptide given alone. This reduction was accompanied by decrease 24-hour food intake (normal rat chow), meal size (MS), duration of first meal and number of meals, and increase latency to the first meal, intermeal interval (IMI) and satiety ratio (IMI/MS, amount of food consumed per a unit of time). Furthermore, the peptides and their combination decreased 24-hour glucose levels. In conclusion, GRP-29 + GLP-1 reduce BW more than each of the peptides given individually.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 35 条
  • [31] Effect of combined administration of Acyl-CoA: Cholesterol acyltransferase 1 inhibitor and glucagon-like peptide 1 receptor agonist on a rodent model of diet-induced obesity
    Kim, Sora Q.
    Kim, Jeonghoon
    Choi, Mulim
    Kim, Young
    Kim, Shin
    Kim, Kee-Hong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 688
  • [32] Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2
    Radziszewska, Elzbieta
    Bojanowska, Ewa
    MEDICAL SCIENCE MONITOR BASIC RESEARCH, 2013, 19 : 6 - 11
  • [33] Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not
    Raun, Kirsten
    von Voss, Pia
    Gotfredsen, Carsten F.
    Golozoubova, Valeria
    Rolin, Bidda
    Knudsen, Lotte Bjerre
    DIABETES, 2007, 56 (01) : 8 - 15
  • [34] Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice
    Leuthardt, Andrea S.
    Boyle, Christina N.
    Raun, Kirsten
    Lutz, Thomas A.
    John, Linu M.
    Le Foll, Christelle
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 955
  • [35] Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of D-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats
    Colvin, Kayla J.
    Killen, Henry S.
    Kanter, Maxwell J.
    Halperin, Maximilian C.
    Engel, Liv
    Dickinson, Matthew B.
    Fimmel, Anna, I
    Holland, James G.
    Currie, Paul J.
    BEHAVIOURAL BRAIN RESEARCH, 2022, 421